Delivery Order SPE2DB24D8002-SPE2DB24FJMQK
Award Date
7/22/24
Potential Completion Date
7/23/24
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a value of $3,306.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This single-award...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJNGD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,575.20, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. This award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, with a ceiling value of $10,030.86 and a period of performance through February 21, 2024. Dakota Drug, Inc. is an established federal contractor, holding a single-award Indefinite Delivery Contract (IDC) with the DLA valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for $10,017.35. The contract is to provide BENLYSTA 200 MG/ML AUTOINJECTML, a biologic drug used to treat autoimmune conditions. This order is not associated with a set-aside program and represents a direct award to Dakota Drug, Inc. as a prime contractor to the DLA Troop Support Medical, which is responsible for supplying medical products...
Dakota Drug, Inc. was awarded a $3,052.69 firm fixed price delivery order against an unidentified contract vehicle to supply the Defense Logistics Agency Troop Support Medical with 4562450170, described as BENLYSTA 200 MG/ML AUTOINJECTML. Performance will take place in Minot, North Dakota, with all work required to be completed by October 12, 2023. No set-aside designation was applied to this award. The Defense Logistics Agency Troop Support Medical supports the medical readiness of armed forces...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $5,863.24 to Dakota Drug, Inc. of Minot, North Dakota. The order is for 200 MG/ML autoinjectors of Benlysta to be delivered to a location in Minot between September 11-12, 2023. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed forces by delivering critical supplies, equipment, and products including pharmaceuticals. This small order for an...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,219.22, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, specifically ZEPBOUND 15 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of March 20, 2025. Dakota Drug, Inc. holds a significant single-award...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical division. The contract was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, and has a total ceiling value of $4,078.18. The contract is a Firm Fixed Price Delivery Order with a performance period through May 21, 2024. Additionally, Dakota Drug, Inc. holds a significant single-award Indefinite Delivery...